Candidaemia with uncommon Candida species: Predisposing factors, outcome, antifungal susceptibility, and implications for management

Sharon C A Chen, D. Marriott, E. G. Playford, Q. Nguyen, D. Ellis, W. Meyer, T. C. Sorrell, M. Slavin, Australian Candidaemia Study

Research output: Contribution to journalArticleResearchpeer-review

68 Citations (Scopus)

Abstract

The risk factors for and clinical features of bloodstream infection with uncommon Candida spp. (species other than C. albicans, C. glabrata, C. parapsilosis, C. tropicals and C. krusei) are incompletely defined. To identify clinical variables associated with these species that might guide management, 57 cases of candidaemia resulting from uncommon Candida spp. were analysed in comparison with 517 episodes of Candida albicans candidaemia (2001-2004). Infection with uncommon Candida spp. (5.3% of candidaemia cases), as compared with C. albicans candidaemia, was significantly more likely to be outpatient-acquired than inpatient-acquired (15 of 57 vs. 65 of 517 episodes, p0.01). Prior exposure to fluconazole was uncommon (n =1). Candida dubliniensis was the commonest species (n =22, 39%), followed by Candida guilliermondii (n = 11, 19%) and Candida lusitaniae (n = 7, 12%). C. dubliniensis candidaemia was independently associated with recent intravenous drug use (p0.01) and chronic liver disease (p0.03), and infection with species other than C. dubliniensis was independently associated with age

Original languageEnglish
Pages (from-to)662-669
Number of pages8
JournalClinical Microbiology and Infection
Volume15
Issue number7
DOIs
Publication statusPublished - 2009

Keywords

  • Antifungal susceptibility
  • Candidaemia
  • Outcome
  • Risk factors
  • Uncommon Candida species

Cite this